Literature DB >> 25698851

Intestinal parasitic infection among Egyptian children with chronic liver diseases.

Lerine Bahy El-Dine El-Shazly1, Amel Abdel Magid El-Faramawy1, Nagwa Mostafa El-Sayed2, Khadiga Ahmed Ismail3, Sally Mohammed Fouad1.   

Abstract

Patients with chronic liver diseases (CLD) are often highly susceptible to parasitic infection due to a depressed immune system. The objective of this study was to detect the most commonly intestinal parasites found among Egyptian children with CLD. The present study was conducted on 50 children with CLD of different etiology (25 were having different intestinal symptoms, 25 without intestinal symptoms) and 50 non-CLD children with gastrointestinal complaints served as controls. All cases were subjected to stool examination and investigated by liver function tests. Also, anthropometric measurements were taken for all children including weight and height. It was found that the most commonly intestinal protozoa identified in the patients with CLD in order of frequency were: Entamoeba histolytica/Entamoeba dispar (16 %), Giardia lamblia (14 %), Blastocystis hominis (14 %), Cryptosporidium parvum (10 %), E. histolytica and G. lamblia (2 %), E. histolytica and B. hominis (2 %), G. lamblia and B. hominis (2 %), B. hominis and Entamoeba coli (2 %), Microsporidium (2 %) and no cases were found infected with Strongyloides stercoralis. As compared to the controls, the observed incidence of these organisms in CLD patients was significantly higher (p < 0.045) as regards stool examination by unstained techniques while, there was no significant difference between both groups as regards stool examination by stained techniques (p < 0.478). In addition, this study showed that the weight and height of studied patients were affected by parasitic infection while, there was no significant correlation between parasitic infection and liver function tests. In conclusion, chronic liver diseases affect the immunity of the patients as shown in significant increase in the incidence of intestinal parasites in cases compared to controls.

Entities:  

Keywords:  Chronic liver diseases; Intestinal parasites; Stool examination

Year:  2013        PMID: 25698851      PMCID: PMC4328027          DOI: 10.1007/s12639-013-0346-x

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  19 in total

1.  Parasitological and bacteriological studies in recurrent diarrhoea in patients with chronic liver diseases.

Authors:  T A Younes; M M Hussein; S M Kamal; D M Mahmoud; S F Metwaly
Journal:  J Egypt Soc Parasitol       Date:  1996-12

2.  Staining of cryptosporidia by a modified Ziehl-Neelsen technique.

Authors:  S A Henriksen; J F Pohlenz
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

3.  Can dietary intake influence plasma levels of amino acids in liver cirrhosis?

Authors:  C Loguercio; F Del Vecchio Blanco; A Nastasi; A Federico; G Del Vecchio Blanco; V De Girolamo; D Disalvo; A Parente; C Del Vecchio Blanco
Journal:  Dig Liver Dis       Date:  2000-10       Impact factor: 4.088

4.  A new acid-fast trichrome stain for simultaneous detection of Cryptosporidium parvum and microsporidial species in stool specimens.

Authors:  R Ignatius; M Lehmann; K Miksits; T Regnath; M Arvand; E Engelmann; U Futh; H Hahn; J Wagner
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  Bacterial and cryptosporidial infection as the cause of chronic diarrhoea in patients with liver disease in Nepal.

Authors:  S Shrestha; S Larsson; J Serchand; S Shrestha
Journal:  Trop Gastroenterol       Date:  1993 Apr-Jun

6.  A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens.

Authors:  N J Ryan; G Sutherland; K Coughlan; M Globan; J Doultree; J Marshall; R W Baird; J Pedersen; B Dwyer
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations.

Authors:  Jorge Humberto Botero; Amanda Castaño; Marta Nelly Montoya; Norma Elena Ocampo; Marta Inés Hurtado; Mónica María Lopera
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2003-09-17       Impact factor: 1.846

8.  Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group.

Authors:  R Weber; R T Bryan; R L Owen; C M Wilcox; L Gorelkin; G S Visvesvara
Journal:  N Engl J Med       Date:  1992-01-16       Impact factor: 91.245

9.  Opportunistic intestinal parasites among children with chronic liver disease.

Authors:  Mohamed H A Hegab; Samir M Zamzam; Nahed M Khater; Doaa M Tawfeek; Hend M Abdel-Rahman
Journal:  J Egypt Soc Parasitol       Date:  2003-12

10.  [Epidemiological, etiological and evolutionary aspects of children cirrhosis in a developing country: experience of the pediatric department of SFAX University hospital, Tunisia].

Authors:  Malek Chaabouni; Sonia Bahloul; Wafa Ben Romdhane; Mounir Ben Saleh; Nabil Ben Halima; Chokri Chouchene; Amel Ben Hmad; Nafissa Zroud; Thouraya Kammoun; Abderrahmen Karray
Journal:  Tunis Med       Date:  2007-09
View more
  3 in total

1.  Echinococcosis Is Associated with the Increased Prevalence of Intestinal Blastocystis Infection in Tibetans and Host Susceptibility to the Blastocystis in Mice.

Authors:  Yang Zou; Yu-Gui Wang; Zhong-Li Liu; Ai-Jiang Guo; Xiao-Lu Li; Zhi-Qi Shi; Xing-Quan Zhu; Xiu-Min Han; Shuai Wang
Journal:  Biology (Basel)       Date:  2022-05-18

2.  Toxoplasma gondii Infection and Chronic Liver Diseases: Evidence of an Association.

Authors:  Nagwa Mostafa El-Sayed; Manar Ezzelarab Ramadan; Mohamed Ezzelarab Ramadan
Journal:  Trop Med Infect Dis       Date:  2016-11-01

3.  Anti-Blastocystis Activity In Vitro of Egyptian Herbal Extracts (Family: Asteraceae) with Emphasis on Artemisia judaica.

Authors:  Amira B Mokhtar; Shahira A Ahmed; Enas E Eltamany; Panagiotis Karanis
Journal:  Int J Environ Res Public Health       Date:  2019-05-03       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.